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Because thyroid nodules are frequent in areas with iodine deficiency the aim of this study was to characterise molecular events during iodine
deficiency that could explain mutagenesis and nodule formation. We therefore studied gene expression of catalytic enzymes prominent for H2O2
detoxification and antioxidative defence, quantified DNA oxidation and damage as well as spontaneous mutation rates (SMR) in mice and rats fed
an iodine controlled diet. Antioxidative enzymes such as superoxide dismutase 3, glutathione peroxidase 4 and the peroxiredoxins 3 and 5 showed
increased mRNA expression, which indicates increased radical burden that could be the cause of additional oxidized base adducts found in
thyroidal genomic DNA in our experiments of iodine deficiency. Furthermore, the uracil content of thyroid DNA was significantly higher in the
iodine-deficient compared to the control group. While SMR is very high in the normal thyroid gland it is not changed in experimental iodine
deficiency. Our data suggest that iodine restriction causes oxidative stress and DNA modifications. A higher uracil content of the thyroid DNA
could be a precondition for C→T transitions often detected as somatic mutations in nodular thyroid tissue. However, the absence of increased
SMR would argue for more efficient DNA repair in response to iodine restriction.
© 2007 Elsevier B.V. All rights reserved.Keywords: Iodine Deficiency; Mutagenesis; Comet Assay; DNA Damage1. Introduction
One of the most obvious clinical manifestations in
geographical areas with iodine deficiency is thyroid enlarge-
ment known as endemic goitre [1]. In the long run this thyroid
enlargement leads to nodular transformation of the thyroid.
Because somatic mutations are a frequent finding in thyroid
adenomas or adenomatous nodules [2–4] which are predomi-
nantly monoclonal [4] molecular events during nodular
transformation very likely involve DNA mutagenesis. This is
further supported by the finding of somatic mutations in
microscopic areas of iodine-deficient euthyroid goiters [5].
However, molecular events during iodine deficiency that could⁎ Corresponding author. IZKF Leipzig, University of Leipzig, Inselstraβe 22,
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doi:10.1016/j.bbamcr.2007.03.011explain mutagenesis and nodule formation have not been
studied so far.
A normal thyroid status is dependent on the presence of
iodine which is a trace element necessary for the synthesis and
metabolism of thyroid hormones. Because iodide is a major
substrate of the synthesis of thyroid hormones thyroxine (T4)
and 3,3′,5-tri-iodothyronine (T3) deficiency is an important
health problem in areas with iodine-deficient soil [6]. Thyroid
hormone synthesis requires the generation of H2O2 as co-
substrate which could be the source of reactive oxygen species
(ROS). In fact, generation of H2O2 is inhibited by iodide in
vivo and in vitro [7–9]. Because these findings imply higher
H2O2 generation in iodine deficiency our attention was focused
on gene products directly involved in H2O2 detoxification and
antioxidative action. Thyrocytes very likely have an effective
mechanism to regulate antioxidative responses that counter
the potential threat of oxidative stress. Therefore, a higher
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dismutase (SOD)-3 which preferentially acts in the lumen (i.e.
where H2O2 is generated) could very likely shield the thyroid
from the toxic effect of H2O2 metabolites and thereby protect
the thyroid from possible H2O2 metabolites induced DNA
damage and somatic mutations. During severe iodine deficiency
limitation of iodine could impair thyroid hormone (TH)
synthesis and cause an compensatory increase in the co-
substrate H2O2 which in turn could extend ROS mediated DNA
damage. To study this hypothesis we used different modifica-
tions of the comet assay (CA) that detect oxidative DNA
damage in the thyroid gland.
Finally we studied the spontaneous mutation rate in the
thyroid under iodine restriction because we recently detected a
8–10 times higher mutation rate in the thyroid from mice versus
liver [10].2. Methods
2.1. Animals
Series 1: Twenty-one days old mixed-sex transgenic mice (mixed-sex C57Bl/
6) containing a lacZ reporter plasmid (pUR288 [11]) to study the rate
of in vivo mutations were fed a diet (Altromin, Lage, Germany) with
either sufficient (purified C1000, 0.4 mg iodine/kg), deficient
(C1042, <0.05 mg iodine/kg) and intermediate iodine (based on
C1000 with only 0.2 mg iodine/kg) for 8 weeks, 3 months and 1 year.
For gene expression studies mixed-sex balbC mice were identically
treated.
Series 2: For quantification of DNA modifications mixed-sex Wistar rats and
mixed-sex balbC mice were fed two diets (Altromin, Lage, Germany)
with or without sufficient iodine for 8 weeks (regular diet C1000:
0.45 mg iodine/kg; I-deficient diet C1042: 0.06 mg iodine/kg).
Water and diet were supplied ad libitum. Ethical approval was given by the
regional board.
2.2. Iodine, T4 and TSH concentration
To collect urine mice (all series) were maintained in metabolic cages (Ehret,
Schönwalde, Germany) for 3 days and rats for 1 day. To control the efficiency
of the diet urinary iodine concentration was measured according to
Wawschinek using a modified Cer-arsenit method [12]. After starting the diet
urinary iodine in the iodine-deficient groups decreased and reached a stable
level 2–3 weeks after starting the diet. Serum TSH was measured in 50 μl of
serum using a sensitive, heterologous, disequilibrium double antibody
precipitation radioimmunoassay as previously described [13]. Samples contain-
ing more than 200 mU TSH/L were 5- and 50-fold diluted with a TSH-deficient
mouse serum.
Serum T4 concentrations were measured by a double antibody precipitation
RIA (Diagnostic Products, Los Angeles, CA) using 25 μl of serum. The
sensitivity of the assay was 0.2 μg T4/dL. The inter-assay coefficients of
variation were 5.4, 4.2 and 3.6% at 3.8, 9.4 and 13.7 μg/dl for T4 [14].
2.3. Tissue preparation
Animals were killed by a carbon dioxide atmosphere at an age of about 2–
3 months (C57Bl/6 also at 1 year). Serum and tissues were collected,
immediately frozen on dry ice and stored at −80 °C or kept at 4 °C until
further processing. Thyroids from the dietary groups were weighed before
freezing. For the comet assay the fresh tissue was minced in mincing solution,
pH 7.5 (HBSS (Ca2+, Mg2+ free), 20 mM EDTA and 10% DMSO) and aliquots
were frozen in liquid nitrogen.2.4. DNA and RNA preparation
Genomic DNA was isolated using the DNA isolation kit from Roche
Diagnostics (Mannheim, Germany) based on cell lysis, proteinase K digest,
DNA binding to silica surface and magnetic bead separation according to the
protocol of the manufacturer.
Total RNA was isolated using TRIzol reagent (Life Technologies,
Gaithersburg, MD, USA) according to the manufacturer's instructions. After-
wards, the total RNA was purified with RNeasy columns (Qiagen, Hilden,
Germany) according to the RNA clean-up protocol.
2.5. Global PolyA-PCR amplification of RNA
To amplify the limited amount of RNA that is available from mouse thyroid
glands we used polyA-PCR according to Brady et al. [15] which was shown to
preserve relative abundance of mRNA species. Briefly, 200 ng of RNA were
reverse transcribed for 15 min using AMV reverse transferase (Roche
Diagnostics, Mannheim, Germany) with limited amounts of dNTP (2 μM
each) to restrict the length of the first strand. In a terminal transferase reaction
(Roche Diagnostics) first strand cDNA was polyA tailed. Finally, the tailed
cDNAwas PCR amplified with a polyT primer in 1× Taq buffer and 10 units Taq
polymerase (Roche Diagnostics) for two times 25 cycles of 1 min at 94 °C,
2 min at 42 °C and 6 min (and additional 10 sec/cycle) at 72 °C in a thermal
cycler (MWG, Ebersberg, Germany).
2.6. Gene specific real time RT-PCR
The quantification of several genes by real time RT-PCR was performed
using a Light-Cycler-DNA Master SYBR Green I Kit (Roche Diagnostics)
according to the manufacturer and a LightCycler (Roche Diagnostics) as
previously described [16]. Oligonucleotide primers were designed to amplify a
120- to 300-bp product in the 3′ region of the respective mRNA. The nucleotide
sequences of the primers and PCR conditions are available on request. A serial
dilution of a known plasmid DNA concentration containing the sequence of the
respective PCR product as an insert was used as standard curve to calculate the
concentration of the PCR product. The determined concentrations were
normalized to the concentration of the housekeeping gene ribosomal protein S6.
2.7. Enzymatic activity of SOD
Superoxide dismutase activity was measured according to Sun et al. [17].
Briefly, frozen samples were grinded using pistil and mortar under liquid
nitrogen cooling. The tissue powder was then homogenized in ice cold 0.1 M
phosphate buffer pH 7.4 and centrifuged at 15000 U/min and 4 °C for 1 h. Ten μl
diluted SOD standards (Calbiochem, Schwalbach/Ts., Germany) for calibration
or diluted homogenates were mixed with 100 μl of the assay reagent (0.1 M
phosphate puffer pH 8; 0.2 mM diethylenetriaminepentaaceticacid (Sigma,
Taufkirchen, Germany); 2 U/μl catalase (Fluca, Taufkirchen Germany); 0.1 mM
terazolium salt (Sigma); 3.5 U/μl xanthinoxidase (Sigma)) in a 96-well plate.
The reactions were started with 1 mM xanthine solution in 0.1 M phosphate
puffer pH 8. Optical density was measured every 3 min for half an hour at
540 nm. Only measurements, where progression of the O.D. curve was linear in
this interval were used for calculation of the enzyme activity.
2.8. Spontaneous mutation rate
To rescue the plasmid derived DNA sequences (pUR288) containing a lacZ
reporter from genomic DNA we followed the protocol by Gossen et al. [18].
Briefly, genomic DNA from different organs of C57Bl/6 transgenic mice was
digested with the restriction enzyme HindIII in the buffer suggested by the
manufacturer (MBI Fermentas, Roth, Germany). Afterwards lacI repressor
bound to magnetic beads was used to separate the plasmid from genomic DNA.
After two washing steps plasmid DNA was eluted with isopropylthio-β-
galactosidase (IPTG). Linear pUR288 DNAwas circularised with T4 ligase for
2 h, precipitated and electroporated into electro-competent Escherichia coli
cells (ΔlacZ/galE) using a Gene-Pulser in combination with a Pulse Controler
(Bio-Rad, Richmond, CA) at a setting of 2.5 kV, 25 μF and 200 Ω. Aliquots of
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agar plates with the lactose-analogue P-gal which only allows colony formation
in lacZ− cells and hence mutation detection [19].
2.9. Comet assay
We followed the protocol described by Miyamae et al., 1998 [20] and by
Tice et al. [21] with some modifications for the detection of oxidized bases using
repair enzymes [22]. A detailed protocol of the assay is given inMaier et al. [10].
Briefly, thyroid tissue was washed and minced into very small pieces in mincingFig. 1. The urinary iodine concentration (A, E), thyroid weight (B, F), T4 (C, G) and T
of the diet (urinary iodine) or at the time of sacrifice (thyroid weight, T4 and TSH). V
diet (black bars). Stars represent the level of significance compared to control diet (solution, pH 7.5 (HBSS (Ca2+, Mg2+ free), 20 mM EDTA and 10% DMSO).
After mixing with 0.6% low melting point agarose in PBS the mixture was
placed on a SuperFrost microscope slide (Roth, Karlsruhe, Germany), first
coated with 1% normal agarose, and later with 0.6% normal agarose/PBS. A
gentle cell lysis and a digest with repair enzymes (Endonuclease III, FPG and
UDG from SIGMA-Aldrich, Saint Louis, USA; 0,02 unit/μl) were carried out
before the cells were treated with alkali to unwind and denature the DNA and
hydrolyze the site of damage [21]. A sample without enzyme digestion was used
as a control. Subsequently, fragmented DNA migrates out of the nucleus in an
alkaline electrophoresis (17 min at 26 V/300mA (1 Volt/cm)) and forms theSH (D, H) were determined in BalbC mice andWistar rats 7 weeks after the start
alues are given as mean±SEM for control diet (white bars) and iodine-deficient
t-test). ***p≤0.001; **p≤0.01; *p≤0.05.
Table 1
Gene expression of thyroid specific genes
Time Iodine diet
0.2 mg/kg <0.05 mg/kg
TSHR 8 weeks 1.26±0.27 1.85±0.31*
3 months 1.18±0.13 1.75±0.36*
1 year 3.15±0.80* 3.14±0.88*
NIS 8 weeks 1.41±0.37 1.85±0.49
3 months 1.72±0.65 3.64±1.17*
1 year 4.79±2.03 9.94±3.86*
TPO 8 weeks 1.66±0.23* 2.13±0.35**
3 months 2.01±0.35* 1.93±0.41*
1 year 2.42±0.64 3.10±0.84*
Expression of mRNA transcripts was quantified in thyroids of iodine deficient
(<0.05 mg/kg), intermediate iodine deficient (0.2 mg/kg) and control (0.4 mg/
kg) balbC mice (series 1) with a Lightcycler (see Methods). Values represent the
mean fold change±SEM (n=6–9 animals per group) of a certain transcript for
the respective diet at different time points compared to the control diet. All
transcripts were normalized to S6 ribosomal protein mRNA.
Stars represent the level of significance compared to control diet (t-test).
***p≤0.001; **p≤0.01; *p≤0.05.
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(SIGMA-Aldrich, Saint Louis, USA) for 20 min.
Fluorescence microscopy was used to classify a minimum of 100 comets
per organ per animal into different types [20], which were defined according
to Maier et al. [10]. All determinations were repeated at least once. The
comet score (CS) was calculated in modification to [23] as sum of the
percentage of each type n (running from 1 to 5) times n-1. For our
examination of 100 comets the score reaches values between 0 and 400.
Scores for the modified CA procedures are expressed as the differences to the
CA procedure alone.
2.10. Statistics
Differences of SMR, mRNA expression and comet scores were analysed
with one way ANOVA. Student's t-test was used for pair-wise comparison of
SMR values and mRNA expression between different diets. Tukey's Multiple
Comparison Test embedded in the GraphPad Prism 4.03 software package
(GraphPad software Inc., San Diego, USA) was used for statistical analysis of
comet scores of all dietary groups. Student's t-test was used for pairwise
comparison. The statistical error is expressed as standard error of mean
(SEM).
3. Results
3.1. Urinary iodine concentration and thyroid weight
To control the efficiency of the diet urinary iodine con-
centration was measured about 7 weeks after starting the diet
(Fig. 1A and E). The urinary iodine concentrations for the
control groups (sufficient iodine) were 9.60±1.61 μg/day
(n=50) and 44.01±4.92 μg/day (n=15) for BalbC mice and
Wistar rats, respectively. In the iodine-deficient groups urinary
iodine concentrations were reduced to 2.50±0.46 μg/day
(n=53) and 11.93±2.10 μg/day (n=16) for mice and rats,
respectively. Urinary iodine concentration in mice with inter-
mediate iodine in the diet (series 1) was reduced to 4.92±
1.08 μg/day (n=15) which corresponds to the content of the diet
for iodine.
As a response to iodine restriction we measured a higher
thyroid weight in mice and rats (Fig. 1B and F). After 8 weeks
BalbC mice showed a 25% increase of the thyroid weight under
iodine-deficient diet (2.30±0.10 mg, n=23) compared to the
diet with sufficient iodine (1.84±0.07 mg, n=26). The thyroid
weight of Wistar rats was 37% higher under conditions of iodine
deficiency (19.73±1.00 mg, n=16) compared to the diet with
sufficient iodine (14.40±0.48 mg, n=16).
3.2. T4 and TSH concentration
Iodine deficiency causes a reduction of T4 levels in BalbC
and Wistar rats (Fig. 1C and G). T4 levels for the control groups
(sufficient iodine) were 5.77±0.18 μg/dl (n=51) and 3.81±
0.19 μg/dl (n=16) for BalbC mice and Wistar rats, respectively.
In the iodine-deficient groups urinary iodine concentrations
were reduced to 4.26±0.22 μg/dl (n=51) and 2.57±0.27
(n=16) for mice and rats, respectively. T4 concentration in mice
with intermediate iodine in the diet (series 1) was reduced to
5.08±0.29 μg/dl (n=15).
TSH under iodine restriction was not or only little changed
(Fig. 1D and H).3.3. mRNA expression of the TSH receptor (TSHR),
sodium-iodine symporter (NIS) and thyroid peroxidase (TPO)
We did not find changes of serum TSH levels in mice under
iodine-deficient diet. However, instead of altered serum TSH
level altered sensitivity to TSH could also trigger a thyroid
response. Therefore we tested the mRNA expression of TSHR
and other proteins relevant for thyroid metabolism.
mRNA expression of the TSHR showed a significant
increase in response to iodine deficiency at 8 weeks, 3 months
and 1 year of severe iodine restriction (Table 1). In contrast,
TSHR expression in mild iodine deficiency was only increased
in the group treated for 1 year (Table 1).
Gene expression of NIS mRNA was significantly increased
at 3 months and 1 year in the group of severe iodine deficiency
(Table 1).
Except for intermediate iodine, a significant increase of TPO
mRNA expression (Table 1) was detected over a 1 year period
in all mice fed a severely iodine-deficient diet.
3.4. mRNA expression of antioxidative acting enzymes
In our previous study we could show that the formation of
mutations in the thyroid is most likely caused by oxygen
radicals which attack DNA [10]. To follow this line of thinking,
we determined mRNA expression for catalytic enzymes of
H2O2 detoxification such as catalase (CAT) and superoxide
dismutases (SODs) 1, 2, 3. Moreover, we studied global
antioxidant genes that code for glutathione-dependent enzymes
(glutathione-S-transferase isoform μ6 (GthT), glutathione
peroxidasese 2 (GPx2), 3 (GPx3) and 4 (GPx4)) or thior-
edoxin-dependent peroxide reductases (peroxiredoxins 1, 3 and
5) (Table 2).
In the first group only SOD-3 showed a significant increase
of mRNA expression (Table 2) that was transient. In the
severely iodine-deficient diet at 8 weeks and after 3 months the
Table 2
mRNA expression of antioxidant enzymes
Time Iodine diet
0.2 mg/kg <0.05 mg/kg
Catalase 8 weeks 0.73±0.17 0.70±0.20
3 months 0.93±0.15 0.81±0.05
1 year 1.11±0.23 1.47±0.52
SOD-1 8 weeks 0.98±0.14 0.89±0.14
3 months 1.00±0.09 0.93±0.10
1 year 1.13±0.14 1.04±0.12
SOD-2 8 weeks 1.04±0.07 0.99±0.06
3 months 0.81±0.08 0.90±0.12
1 year 0.94±0.27 1.15±0.19
SOD-3 8 weeks 1.45±0.20* 2.70±0.44**
3 months 1.41±0.17* 1.70±0.33*
1 year 1.02±0.08 1.17±0.19
GPx2 8 weeks 1.32±0.37 1.01±0.34
3 months 1.06±0.18 1.17±0.08
1 year 1.28±0.14 1.47±0.29
GPx3 8 weeks 1.21±0.15 0.73±0.08*
3 months 0.76±0.09* 0.89±0.11
1 year 1.47±0.22 1.44±0.34
GPx4 8 weeks 1.78±0.19** 1.87±0.51*
3 months 1.04±0.10 1.19±0.1
1 year 1.19±0.11 1.20±0.16
GthT 8 weeks 1.32±0.11 0.71±0.09*
3 months 0.67±0.06* 0.86±0.15
1 year 0.70±0.12 0.68±0.16
PRDX1 8 weeks 1.05±0.10 0.95±0.10
3 months 1.02±0.07 0.94±0.06
1 year 1.00±0.06 1.07±0.13
PRDX3 8 weeks 1.33±0.10** 1.30±0.07**
3 months 0.95±0.06 0.91±0.07
1 year 1.10±0.06 1.09±0.13
PRDX5 8 weeks 1.50±0.21* 1.52±0.09***
3 months 0.97±0.05 1.08±0.06
1 year 0.99±0.09 1.08±0.15
Expression of mRNA transcripts was quantified in thyroids of iodine deficient
(<0.05mg/kg), intermediate iodine deficient (0.2mg/kg) and control (0.4mg/kg)
balbC mice (series 1) with a Lightcycler (see Methods). Values represent the
mean fold change±SEM (n=6–9 animals per group) of a certain transcript for
the respective diet at different time points compared to the control diet. All
transcripts were normalized to S6 ribosomal protein mRNA.
Stars represent the level of significance compared to control diet (t-test).
***p≤0.001; **p≤0.01; *p≤0.05.
Fig. 2. SOD activity was determined 8 weeks after the start of the diet in Wistar
rats (control diet—white bars; iodine-deficient diet— black bars (n=10 animals
per group)). SOD activity (mU/μg total protein) is given as mean±SEM. Stars
represent the level of significance compared to control diet (t-test). ***p≤0.001;
**p≤0.01; *p≤0.05.
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the diet group with mild iodine deficiency we detected an
increase of 45% at 8 weeks and 41% at 3 months for SOD-3
mRNA expression.
In the group of glutathione-dependent enzymes three
enzymes showed significant changes in response to iodine
deficiency at 8 weeks and 3months (Table 2). mRNA expression
for GPx4 was significantly increased (78% to 87%) at 8 weeks in
both iodine-deficient diets. mRNA expression for GPx3 showed
a significant decrease (27%) in the severely iodine-deficient diet
at 8 weeks and a 24% decrease at 3 months in the diet group with
mild iodine deficiency. GthT expression was significantly
decreased after 3 months of mild iodine deficiency (33%) and
8weeks after severe iodine deficiency (29%). mRNA expression
for GPx2 was unchanged in response to iodine deficiency at the
time points studied (Table 2).Among the peroxyredoxins two of the three enzymes
transiently showed a significant increase of expression in
response to iodine deficiency at 8 weeks. mRNA expression for
PRDX3 and 5 was significantly increased (30% to 52%) at
8 weeks in both iodine-deficient diets (Table 2).
3.5. Superoxide dismutase activity (SOD)
As shown in Fig. 2 the enzymatic activity of SOD was
significantly increased under iodine restriction (by 39%),
respectively.
3.6. Comet assay (CA)
Expression and activity of antioxidative acting enzymes
suggests an increased oxidative stress during iodine deficiency.
To study possible consequences for DNA integrity we used the
comet assay as a sensitive and rapid method for measuring
DNA double- and single-strand breaks and alkali-labile sites.
Moreover three DNA repair enzymes were used to monitor the
steady state level of uracile (uracil-N-glycosylase (UDG)),
oxidized pyrimidine (Endonuclease III (E3)) and modified
purine bases (formamidopyrimidine DNA glycosylase (FPG))
of thyroid DNA. Comet scores with and without prior digestion
are given in Fig. 3.
The CA assay without further enzymatic digestion allows
quantification of strand breaks and alkaline labile sites such as
apurinic/apyrimidinic sites (Fig. 3A).
UDG catalyses the cleavage of uracil base residues from
both single- and double-stranded DNA [24]. The iodine-defi-
cient rats had a 1.6-fold significantly higher uracil content (CS
of 139±7, p<0.001) versus control group (88±7) (Fig. 3B).
Endonuclease III is an iron–sulfur containing DNA repair
enzyme [25] that removes pyrimidine modifications like
thymine glycol, 5-hydroxycytosine and 5,6-dihydrothymine
[26,27]. It also lyses abasic sites [28]. E3 modified CA detects a
1.7-fold higher content of pyrimidine adducts in the iodine-
deficient group (CS of 121±10, p<0.001) versus control
animals (CS of 72±6) (Fig. 3C).
Fig. 3. Steady-state level of DNA damage detected with the comet assay (A) or different modifications of this assay (B–C). Cell nuclei of thyroid glands were prepared
from rats feed for 8 weeks with two diets (control diet— white bars; iodine-deficient diet— black bars. The comet (A) assay detects DNA strand breaks and alkaline
labile sites. UDG modification (B) detects uracil bases in nuclear DNA. Modification with endonuclease III (C) and FPG (D) detects oxidation related base
modifications. All data are expressed as mean±SEM (n=4 animals per group). Significant differences were assessed by ANOVAwith repeated measures followed by
Tukey's Multiple Comparison Test. Stars represent the level of significance compared to control diet (t-test). ***p≤0.001; **p≤0.01; *p≤0.05.
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pathway [29]. It catalyses the excision of a broad spectrum of
modified purines (e.g. formamidopyrimidine and 8-OHdG).
FPG modified CA detects a 1.4-fold higher content of modified
purines in the iodine-deficient group (CS of 133±6, p<0.001)
compared to controls (92±8) (Fig. 3D).Fig. 4. The spontaneous mutation rate was studied in the thyroid gland of
transgene lacZ reporter mice (series 1) fed a iodine deficient (black bars) and
intermediate iodine-deficient diet (striped bars) versus a diet without iodine
restriction (white bars) for 8 weeks to 1 year. For comparison SMR in liver was
determined after 3 months. Given are the average numbers and standard error of
mean (n=4–7 animals per group) of mutated lacZ molecules per 105 wild-type
lacZ molecules. All differences of thyroid tissues versus liver are highly
significant (p<0.001, t-test).3.7. Spontaneous mutations rate (SMR) in the thyroid under
iodine restriction
Mice transgenic for a lacZ reporter construct based on the
plasmid pUR288 were used to determine the SMR in the
thyroid. As shown previously SMR in the thyroid gland ranges
from 56×10−5 to 72×10−5 mutants per wild-type sequence. In
contrast the mutation rate in liver is significantly lower with
numbers from 6.6×10−5 to 7.4×10−5 (about 10% of the
thyroid level). Fig. 4 shows results for SMR during iodine
deficiency for 8 weeks, 3 months and 1 year. Iodine restriction
does not significantly change the SMR in the thyroid gland
which ranges from 45×10−5 to 68×10−5 mutants per wild-type
sequence.
4. Discussion
Iodine deficiency is known as one of the most potent
goitrogens which in the long run is the likely prerequisite for
nodular transformation and hyperthyroidism [4,30]. Because
previous data from our group [10] and others [31,32] suggest
that the thyroid might comprise a mutagenic environment, the
aim of this study was to characterise molecular events during
iodine deficiency that could explain mutagenesis and nodule
formation. We first established an animal model of iodine
restricted diet in mice to better understand early changes after
iodine deficiency. Although not challenged with total iodine
discharge as in many other models of iodine restriction, our mice
and rats develop a mild goitre within a few weeks. Moreover,
during iodine deficiency T4 levels decrease significantly (see
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changed which led us to consider an alternative explanation for
increased thyroid weight or decreased T4 expression. A higher
TSH sensitivity has long been suggested as another mechanism
to cope with iodine deficiency in the thyroid [33]. Our finding of
increased expression of the TSHRmRNA is the first evidence of
how increased sensitivity could be accomplished at the
molecular level. Also increased sodium-iodide symporter
(NIS) gene expression is likely an adequate response to more
effectively transport iodine from blood into the thyroid cell. In
fact, increased NIS expression during iodine deficiency could
reflect the release of negative control seen during high iodide
[34]. Moreover, a higher TPO mRNA expression level during
iodine deficiency could ensure a more effective iodination of
thyreoglobulin.
H2O2 generation which is mandatory for the organification of
iodine is stimulated by TSH/cAMP [35] and under negative
control of iodide [9]. Low iodine andmarkers of increased thyroid
functionality suggest activated H2O2 generation which could
result in DNA damage and somatic mutation [36]. To follow this
line of thinking we intended to get an overview of cellular
regulation concerning enzymes involved in defence against
oxidative stress. Our primary interest was focused on gene
products directly involved in H2O2 turnover. We first studied
mRNA expression of key enzymes (i.e. CAT and SOD-1 to -3)
involved in H2O2 and superoxide detoxification. We detected a
higher mRNA expression for the SOD-3 isoform and increased
total SOD enzyme activity in the thyroid exposed to iodine
deficiency compared to normal diet. Especially increased SOD-3
expression, which is the extra cellular SOD isoform, could
detoxify superoxide in the follicular lumen and might act as an
effective shield against oxidative stress caused by ROS in
response to luminal H2O2. With these results we studied
glutathione-dependent enzymes (GPx2–4 and GthT) that form a
more general defence against oxidative stress and have also
attracted attention in DNA repair [37]. Again, mRNA expression
of three of these enzymes (i.e. GPx3, GPx4 and GthT) transientlyFig. 5. Time course of changes in the mRNA expression of thyroid marker genes and
(t-test). p≤0.001 (black bar); p≤0.01 (grey bar); p≤0.05 (striped bar).changes under iodine deficiency. Moreover, two peroxiredoxins
(i.e. PRDX3 and PRDX5) that have been connected to H2O2
detoxification [38] show increased mRNA expression at 8 weeks
of iodine-deficient diet. This is in line with studies by the group of
Many et al. [39] who show strongly increased immuno-labelling
of PRDX5 in goitrous rats fed a low iodine diet. All together,
changes of SOD, peroxiredoxins, glutathione peroxidases and
transferases after 8 weeks to 3 months of diet indicate a stimulus
very likely linked to the increased production of reactive oxygen
species. While increased expression of SOD-3, PRDX3/5 and
GPx4 might effectively reduce H2O2 related oxidative stress,
reduced expression of GPx3 and GthT is more difficult to
interpret. A possible explanation for reduced extracellular GPx3
lies in the dual functioning of this enzyme. Howie and their group
provide evidence that the primary role of GPx3 might be the
modulation of H2O2 supply for thyroid hormone synthesis rather
than exerting a protective effect on colloid against possible
oxidative cellular damage [40]. Because H2O2 generation is the
limiting step in the TH-synthesis [41,42], a reduced extracellular
GPx3would lead to higher levels of this co-substrate, which could
stimulate TH-synthesis. It is also possible that the two enzymes
usually detoxify peroxides,which are diminished because ofmore
effective antioxidant activity, or only formed during thyroid
hormone metabolism when sufficient iodine is present (e.g.
caused by radicals of iodine). Reduced concentration of these
peroxide substrates could loop back to the regulation of
transcription and reduce mRNA expression. Moreover, different
enzymes or isoforms could be independently regulated by
extracellular stimuli (e.g. growth factors) which has been shown
for PRDX1 and 2 or the thiol-specific antioxidant gene and TSH
stimulation [38,43].
In general, we find an inverse relation between transient
changes of antioxidant gene expression (inclusive of SOD-3
activity) at 8 weeks to 3 months and expression of TSHR, NIS
and TPO mRNA that is highest after 1 year of iodine deficiency
(Fig. 5). This could indicate a compensatory mechanism. We
therefore speculate that increased TSH sensitivity as a result of aantioxidant genes during iodine deficiency expressed as the level of significance
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iodine deficiency, reduce oxidative stress and consequently
normalize gene expression of antioxidant enzymes.
Because differential expression of antioxidant enzymes
implies oxidative stress that could cause DNA damage we
studied steady state levels of DNA base modifications using the
comet assay. Our experiments show a significant increase of
uracile and oxidized purine/pyrimidine adducts in thyroid DNA
under iodine deficiency. The increase of uracile modifications
under iodine restriction could be an explanation for the high
frequency of C→T base changes in TSH receptor mutations
that are found in autonomous functioning thyroid nodules
(AFTN) in iodine-deficient areas [10]. Uracil in DNA may arise
from spontaneous hydrolytic or enzymatic deamination of
cytosine or from misincorporation of dUMP instead dTMP
during DNA replication [44–47]. Deamination of cytosine
generates G:U mismatches that cause G:C to A:T transitions
[48–51]. In contrast, misincorporation of dUMP during DNA
replication does not cause a base change. Uracil in double- and
single-stranded DNA is recognised and excised by the
glycosylases UNG2 (uracil-DNA glycosylase 2) and SMUG1
(single-strand selective monofunctional uracil-DNA glycosy-
lase 1) [52]. An insufficient repair could lead to mutations in
genomic DNA. Our theory of an increased oxidative burden in
the thyroid gland through iodine deficiency is also supported by
increasing steady state levels of oxidized DNA bases detected
as EIII and FPG specific sites in the comet assay. For example,
one of these modifications (i.e. 5-formyl-2′deoxyuridine)
induces T→C and C→T transition as well as G→T trans-
versions [53], which are also very prominent in the spectrum of
somatic activating TSHR mutations found in AFTNs [10].
Furthermore, C→T transitions are also the result of another set
of cytosine modifications (i.e. 5-hydroxycytosine, 5-hydro-
xyuracil, and uracil glycol) detected with the EIII/FPG assay
[27,54].
Because DNA damage is the substrate for mutagenesis we
tested the effect of iodine-deficient diet on the spontaneous
mutations rate (SMR) in mice. While SMR is very high in the
normal thyroid gland it is not changed in experimental iodine
deficiency. There are several possible explanations for this
finding. First of all the effect of iodine deficiency in our model
might not be sufficient to induce an increase of spontaneous
mutations. This could be also reflected in the rather mild
increase in thyroid weight and the lack of TSH increase in the
iodine-deficient groups. Perhaps a pronounced increase of
serum TSH caused by a total iodine discharge is necessary to
detect an increased SMR. It is possible that the SMR in the
thyroid gland has reached a plateau at which only more severe
stimuli can cause an effect. In this regard we could speculate
that an increase of TSH that is detected in models of more
severe iodine deficiency might facilitate spontaneous mutation.
In our model additional oxidative attack is very likely
neutralized by antioxidant activity or oxidative damage is
more efficiently repaired. Such a hypothesis is also supported
by the lack of an aging effect on SMR in the thyroid which is
often detected in other tissues [55,56] that show a much lower
basal SMR compared to thyroid. Moreover, unchanged SMRcould reflect the technical limitation of the detection system that
does not allow to detect transcription based DNA damage which
preferentially occurs when DNA is single-stranded (e.g.
cytosine deamination which is about 100-fold more frequent
in single-stranded DNA). In addition, the lacZ reporter is not
sensitive to silent point mutations and might not detect
mutations that only cause conservative amino acid changes.
Therefore, single base DNA damage as shown during iodine
deficiency might not trigger detection by the lacZ reporter.
In conclusion, we report effects of iodine-deficient diet on the
TH axis, thyroid physiology and antioxidant activity as well as
thyroid DNA modification. Our data also suggest that iodine
deficiency initiates a transient oxidative attack and DNA
modification. However, our model for detection of the
spontaneous mutation rate is very likely not sensitive enough
to see these effects pushed through to the thyroid mutation rate.
Nevertheless, we demonstrate that the thyroid response to iodine
deficiency is not only restricted to enlargement but very likely
involves cellular hyperfunction as suggested by increased
mRNA expression of the TSHR, NIS and TPO. Over time a
more effective use of iodine through increased cellular function
might decrease oxidative stress.
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